VTYX News and Press, Ventyx Biosciences Inc. From 11/07/23

2023-11-07 12:51:35 ET Gainers: PaxMedica ( PXMD ) +78% . Jaguar Global Growth Corp I ( JGGC ) +62% . Transmedics Group ( TMDX ) +54% . Baiyu Holdings ( BYU ) +48% . Fathom Digital Manufacturing Corporation ( FATH ) +46% . Ko...

2023-11-07 11:45:16 ET Summary Today, we look at Ventyx Biosciences, Inc., a clinical-stage biopharma company focused on developing small molecule products for inflammatory diseases. The company has now had two major trial disappointments in the span of a month, triggering a huge ...

2023-11-07 08:36:07 ET Losers: Ventyx Biosciences ( VTYX ) -76% announces results from the phase 2 trial of VTX958 in patients with moderate to severe plaque Psoriasis and provides corporate update. Alto Ingredients ( ALTO ) -50% reports third quarter 2023 re...

2023-11-07 05:25:09 ET Related stories Coherus BioSciences, Inc. (CHRS) Q3 2023 Earnings Call Transcript Alteryx, Inc. (AYX) Q3 2023 Earnings Call Transcript TransMedics Group, Inc. (TMDX) Q3 2023 Earnings Call Transcript The S&P 500's Market Regime Reest...

2023-11-06 17:38:29 ET Gainers: TransMedics  ( TMDX ) +35% . EverQuote ( EVER ) +20% . Vimeo ( VMEO ) +13% . TaskUs  ( TASK ) +13% . TripAdvisor ( TRIP ) +11% . Losers: Ventyx Biosciences ( VTYX ) -74% ....

2023-11-06 17:03:58 ET More on Ventyx Biosciences Ventyx: Promising, But Data Will Need To Justify Optimistic Valuation Ventyx Biosciences, Inc. (VTYX) Q2 2023 Earnings Call Transcript Ventyx stock plunges following Phase 2 results for ulcerative colitis drug ...

VTX958 225 mg BID and 300 mg BID doses achieved statistical significance on the primary endpoint (PASI 75) and all key secondary endpoints at Week 16 Efficacy results did not meet the internal target to support further development of VTX958 in psoriasis; Ventyx to terminate Phase 2 trials...

Ventyx Biosciences Inc. (VTYX) is expected to report $-0.88 for Q3 2023

2023-10-11 16:49:40 ET More on Ventyx Biosciences Ventyx stock plunges following Phase 2 results for ulcerative colitis drug Seeking Alpha’s Quant Rating on Ventyx Biosciences Historical earnings data for Ventyx Biosciences For further details see: ...

2023-10-10 13:10:42 ET More on 5E Advanced Materials 5E Advanced Materials, Inc. (FEAM) Q4 2023 Earnings Call Transcript 5E Advanced Materials hires new contractors to complete small scale boron facility Seeking Alpha’s Quant Rating on 5E Advanced Materials ...